Ghanaian consumption patterns towards fast food are evolving.
Academic rigour, journalistic flair
Articles on Public health
Displaying 801 - 820 of 2121 articles
Vaccine hesitancy will not go away fast. In fact, there are parallels in the physical world to how quickly or slowly an object returns to its normal state.
Nigerian women’s experiences of conflict mirror their unequal status and the prevalence of gender violence in and out of conflict.
Getting pharmacies more involved could be a game changer, particularly for reaching minorities, older adults without internet access and others left behind.
The results indicate that the vaccine efficacy in the UK was 89% for individuals who received at least two doses of vaccine. In South Africa, the vaccine efficacy was 60% in people without HIV.
CC BY-NC-ND17.6 MB (download)
The Novavax vaccine is the first that provides objective scientific evidence that it can protect people against the variant virus circulating in South Africa.
Many of these diseases cause tremendous suffering and death – yet there’s still a lack of effective tools to diagnose, treat, and prevent them.
Studies have shown that highlighting individual responsibility isn’t quite as effective as it seems
History holds some lessons about when scaring people to change their behavior works. Two public health experts offer a case for caution right now.
Almost half of Australian adults struggle with reading. Our recent analysis of government information on COVID-19 found many documents were inaccessible to struggling readers.
Studies in poor countries have highlighted disparities in respectful and responsive care during childbirth based on women’s socioeconomic status and other characteristics.
Workplace-based interventions could make a substantial contribution to reducing the burden of noncommunicable diseases in the country.
Almost a third of legislatures had no direct oversight over the initial responses to the pandemic.
New law has significant implications for researchers in general, and for those involved in the health sector in particular.
Jackson Mthembu’s death drives home the seriousness of the COVID-19 pandemic in the country.
Scientists have observed that 501Y.V2 has quickly become “dominant” among multiple variants that have been circulating in the South African population.
The pervasive impacts of infrastructure projects on public health are often overlooked. New research is teasing out the many ways Melbourne’s level-crossing removals will affect people’s health.
Vaccine hesitancy has resulted in multiple vaccine-preventable disease outbreaks. Research on vaccine hesitancy in South Africa is limited. But growing evidence suggests that it’s becoming a problem.
When a pandemic hits, questions that immediately arise include what impact there will be on public health, the economy and other aspects of society. Another set of questions involves response priorities…
From designing vaccine supply chains to improving PPE to rebuilding trust, systematically bringing engineering knowhow to public health problems could make a huge difference.
Job Board
-
Program Manager, Teaching & Learning Initiatives
-
Lecturer/Senior Lecturer, Earth System Science (School of Science)
-
Sydney Horizon Educators (Identified)
-
Deputy Social Media Producer
-
Associate Professor, Occupational Therapy
Top contributors
-
Emeritus Professor in Public Health, University of Sydney
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Principal Medical Scientist and Head of Laboratory for Antimalarial Resistance Monitoring and Malaria Operational Research, National Institute for Communicable Diseases
-
Research Scientist, African Population and Health Research Center
-
Professor and Programme Director, SA MRC Centre for Health Economics and Decision Science - PRICELESS SA (Priority Cost Effective Lessons in Systems Strengthening South Africa), University of the Witwatersrand
-
Executive Secretary, Nigerian Academy of Science
-
Medical scientist, National Institute for Communicable Diseases
-
Regional Adviser, Immunisation, WHO Regional Office for Africa, Stellenbosch University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Distinguished Professor in the Department of Medicine and Director, The Centre for Medical Ethics & Law, Stellenbosch University
-
Fellow, Nigerian Academy of Science
-
Professor in the faculty of Medicine, Mbarara University of Science and Technology
-
Associate Professor, Epidemiology, Deakin University
-
Medical Entomologist at the School of Biological Sciences, University of Nairobi
-
Communications Specialist, University of California, San Francisco
